MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

July 19 2018 The medicines regulator has issued a Drug Safety Update relating to suspected...

APPG calls for long term conditions to be part of new pharmacy contract

APPG calls for long term conditions to be part of new pharmacy contract

July 16 2018 Community pharmacy’s involvement in managing long term conditions should be...

NICE updates guideline on rheumatoid arthritis

NICE updates guideline on rheumatoid arthritis

July 13 2018 NICE has issued a new version of its guideline on the management of rheumatoid...

RPS seeks views on draft guidance around polypharmacy

RPS seeks views on draft guidance around polypharmacy

July 13 2018 The Royal Pharmaceutical Society is seeking comments to hone draft guidance on...

NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

July 11 2018 New Medicines Service data indicates community pharmacists manage 19 out of 20...

  • MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

    MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

    Thursday, 19 July 2018 10:29
  • APPG calls for long term conditions to be part of new pharmacy contract

    APPG calls for long term conditions to be part of new pharmacy contract

    Monday, 16 July 2018 15:44
  • NICE updates guideline on rheumatoid arthritis

    NICE updates guideline on rheumatoid arthritis

    Friday, 13 July 2018 12:51
  • RPS seeks views on draft guidance around polypharmacy

    RPS seeks views on draft guidance around polypharmacy

    Friday, 13 July 2018 12:47
  • NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

    NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

    Wednesday, 11 July 2018 13:02

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a doctor consulting young lady imageJuly 4 2018

A new model of care with community pharmacists providing a day’s support each week to a general practice could release 18 million GP appointments nationally.

Outcomes from a pilot scheme in Sheffield has found that “for every day of dedicated community pharmacist support for general practice, one whole session of GP clinical time is created, meaning an additional 25 patients can see their GP every week.”

The scheme was funded through the Prime Minister’s Challenge Fund (PMCF). Basegreen Pharmacy provided dedicated community pharmacy support to the Jaunty Springs Medical Centre located on a post-war housing estate in a Sheffield suburb. The practice has a list size of around 3,600 patients and its population is generally older than the Sheffield and England average.

A report on the scheme has been published by the National Pharmacy Association. It explains: “Through IT integration and a formal partnership agreement between the community pharmacy and the general practice, the community pharmacist was able to undertake appropriate consultations within the community pharmacy setting. 

“Read/write access to the full GP clinical record enabled real time information sharing and allowed the community pharmacist to make full use of their training and knowledge as the NHS medicines expert. Patients were proactively directed towards the pharmacy as a source of care, reducing demand on the practice, and improvements in the patient experience as they were able to be seen more quickly as the community pharmacist was more readily available.”

If rolled out nationally, the scheme could free up 18 million GP appointments a year, said the NPA. 

NPA Chair Nitin Sodha said: “On average there is one GP based pharmacist for 30,000 patients, which is nowhere near the scale required to meet current and future demand. In comparison, in Sheffield, the ratio was one community pharmacist for a practice population of 3500, plus the added resource of the pharmacy support staff.  

“Since NHS England has invested heavily in the General Practice Pharmacist Scheme, there is surely a strong justification for investment in pharmacy-based schemes which deliver similar benefits but can cater for many more patients, conveniently and probably at lower cost.”

Mr Sodha has called on NHS England to review this alternative model in more detail and to ensure funding is allocated from the Pharmacy Integration Programme to support the fuller deployment of the community pharmacy network.

Pharmacist Garry Myers, the owner of the pharmacy and an executive partner in the surgery, said without support from the pharmacy the surgery could have closed. 

“The experience of working in this way was beneficial for Basegreen Pharmacy and Jaunty Springs Medical Practice, which may not have survived without this partnership, as it was being overwhelmed by the needs of the local population. But above all, it’s been great for patients in the area, who have benefited from the improved access to medicines support,” he said.  

“We have adopted the successful principle that any patient that could be well-managed by the community pharmacist should be referred there to reduce practice workload, improve the patient experience and encourage positive patient attitudes towards self-care.”

Commenting on the report, PSNC Chief Executive, Simon Dukes, said: “The Jaunty Springs model gives us yet another excellent example of the many ways in which enabling community pharmacists to provide more care for patients could have a positive impact on GP practices, helping them to manage the growing pressure they are under. 

“The benefits to patients and to wider NHS services, including in economic terms, are also clearly evident from this report. Integration of community pharmacy services with other healthcare providers is something that we will continue to support and work towards, and we very much hope to see examples of successful joint working like this becoming the norm, rather than the exception.”

Links:
NPA announcement     
G Myers & J Roach. ‘New Models of Care Supporting General Practice through Community Pharmacy’. July 3 2018.         

Practice News

July 19 2018 The medicines regulator has issued a Drug Safety Update relating to suspected adverse drug reactions associated with medicines taken during pregnancy.
July 11 2018 New Medicines Service data indicates community pharmacists manage 19 out of 20 hypertensive patients without the need to refer a patient back to the GP. Analysis of 131,419 patient...